Cita APA

Larsson, S. C., & Gill, D. (2021). Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling as a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer’s Disease. Nutrients.

Citación estilo Chicago

Larsson, Susanna C., y Dipender Gill. "Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling As a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer’s Disease." Nutrients 2021.

Cita MLA

Larsson, Susanna C., y Dipender Gill. "Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling As a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer’s Disease." Nutrients 2021.